2007
DOI: 10.1111/j.1469-0691.2007.01749.x
|View full text |Cite
|
Sign up to set email alerts
|

Distribution and expression of macrolide resistance genes in coagulase-negative staphylococci

Abstract: In total, 494 isolates of coagulase-negative staphylococci (CoNS) were identified to the species level by biochemical tests and sodA sequencing. Erythromycin resistance phenotypes were determined and specific resistance genes were identified by PCR. The prevalence of erythromycin resistance varied widely among staphylococcal species, from 0% in Staphylococcus lugdunensis to almost 90% in Staphylococcus haemolyticus. Most (63%) erythromycin-resistant isolates carried constitutively expressed erm(C) as the sole … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
46
2
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 78 publications
(65 citation statements)
references
References 30 publications
13
46
2
4
Order By: Relevance
“…The resistance to macrolides and tetracycline may occur due to several mechanisms in addition to efϐlux pump, such as modiϐication enzymes and ribosome protection (Butaye et al 2003, Gatermann et al 2007, Hassan et al 2007). The results showed high resistance rates against erythromycin in S. caprae (43%), S. epidermidis (43%), and in other non-identiϐied CNS (56%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The resistance to macrolides and tetracycline may occur due to several mechanisms in addition to efϐlux pump, such as modiϐication enzymes and ribosome protection (Butaye et al 2003, Gatermann et al 2007, Hassan et al 2007). The results showed high resistance rates against erythromycin in S. caprae (43%), S. epidermidis (43%), and in other non-identiϐied CNS (56%).…”
Section: Discussionmentioning
confidence: 99%
“…Possible differences in phenotypic and genotypic resistance to erythromycin may be explained by other unidentiϐied macrolide resistance mechanisms which are common in CNS isolates (Fiebelkorn et al 2003). These are ultimately related to geographic location and therapeutic drug usage (Pitkälä et al 2004, Gatermann et al 2007). The presence of two or more antimicrobial resistance genes may be associated with multidrug resistant Staphylococcus spp.…”
Section: Discussionmentioning
confidence: 99%
“…A diferença de resistência fenotípica e genotípica à eritromicina pode ser explicada por algum outro mecanismo de resistência a macrolídeos ainda não estudado que pode ser usual em isolados de SCN (FIEBELKORN et al, 2003). A ocorrência de outros mecanismos de resistência para eritromicina são relacionadas com variações quanto à localização geográfica e uso terapêutico destes fármacos (GATERMANN; KOSCHINSKI;FRIEDRICH, 2007;PITKÄLÄ et al, 2004).…”
Section: Resultsunclassified
“…Este gene é de fundamental importância, pois está relacionado com o mecanismo de bomba de efluxo, que favorece a resistência aos macrolídeos e tetraciclina. Todavia, outros mecanismos, como enzimas de modificação e proteção ribossômica, também podem contribuir para o aumento da resistência que os microorganismos apresentam a alguns antimicrobianos (GATERMANN; KOSCHINSKI; FRIEDRICH, 2007;HASSAN;SKURRAY;BROWN, 2007). Neste estudo, apenas um isolado foi produtor de bomba de efluxo, porém, quatro foram considerados positivos para o gene msrA.…”
Section: Resultsunclassified
“…Bacteriol., 8 (3): 48-61, 2015 accounted for 54% of similar incidence in infants (Vergnano et al, 2011). The occurrence of CoNS have also been commonly associated with various medical devices such as prosthetic valves, cerebrospinal fluid shunts as well as intravascular, urinary and dialysis catheters (Chaudhury and Kumar, 2007;De Allori et al, 2006;Gatermann et al, 2007;Koksal et al, 2009;Rasigade et al, 2012).…”
Section: Introductionmentioning
confidence: 99%